retatrutide peptide clinical trial results Experimental drug shows promising in Retatrutide Results: 24% Weight Loss

If approved, it would represent a significant milestone, becoming the first oral GLP-1 treatment specifically for obesity with an efficacy profile on par with the most potent injectables

It keeps dinner fun, flexible, and easy for busy moms

Abbreviations CNS: Central nervous system CVOT: Cardiovascular outcome trial GIP: Glucose-dependent insulinotropic polypeptide GIPR: Glucose-dependent insulinotropic polypeptide receptor GLP-1: Glucagon-like peptide-1 GLP-1R: Glucagon-like peptide-1 receptor GLP-1RA: Glucagon-like peptide-1 receptor agonist GPR: G-protein-coupled receptor HFpEF: Heart failure and preserved ejection fraction IEL: Intraepithelial lymphocyte LPS: Lipopolysaccharide MACE: Major adverse cardiovascular events MPGF: Major proglucagon fragment MTC: Medullary thyroid cancer NASH: Non-alcoholic steatohepatitis SGLT: Sodiumglucose cotransporter WAT: White adipose tissue References Bayliss WM, Starling EH (1902) The mechanism of pancreatic secretion

The technical contact for the docket is Takyiah Stevenson at the Center for Drug Evaluation and Research, reachable at [email protected] or 240-402-2507